On June 5, Philip Morris International rose 3.06% in regular trading, trading at $180.24/share, with trading volume of $355 million.

On the news front, Morgan Stanley identified the company's US launch of Zyn Ultra nicotine pouches as a potential stock catalyst. Philip Morris announced at an investor conference that it is rolling out Zyn Ultra in the US this month in 9- and 11-milligram strengths across a range of flavors similar to its original Zyn offerings, following the FDA's new enforcement guidance for nicotine pouches and e-vapor products. Morgan Stanley also highlighted that the company's heat-not-burn category in Japan has been roughly matching expectations, with IQOS maintaining market share stability even after a significant excise tax-driven price increase on April 1. The firm projected above-consensus earnings for the company.

Within the Tobacco sector, the broader group showed strength. Among individual stocks, British American Tobacco up 4.28%, Altria up 3.6%, Universal up 2.14%, Turning Point up 0.07%, RLX Technology down 0.5%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)